Contrast Media The Product - Sanochemia
Contrast Media The Product - Sanochemia
Contrast Media The Product - Sanochemia
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
A Company with Attractive <strong>Product</strong>s<br />
Spasticity<br />
<strong>The</strong> <strong>Product</strong> – TOLPERISONE<br />
<strong>Product</strong> advantage<br />
• Centrally acting muscle relaxant: improved administration form for IR formulation,<br />
non-sedating or with minimal sedative effect<br />
Competitive edge<br />
• Established drug substance (Eastern Europe), known risk profile<br />
• EU patent protection of the API production process until at least 2022<br />
Status quo/prospects<br />
• Marketing authorisation in Germany (April 2007): Viveo ® – brand name of Orion Corp.<br />
• Additional registrations sought via national filings and MRP (start in 2008)<br />
• Clinical trials in the US with Avigen in the indications MS and spinal cord injuries<br />
• Out-licensing to Avigen (USA) in 2006, Orion (D, CH, Scandinavia and Baltic States)<br />
in 2007, other territories planned<br />
18
Change language